Technology ❯Biotechnology

Genetic Research

Species Resurrection Health Innovations Consumer Genetics Molecular Biology Transcription Factors CRISPR Applications Cloning Species Revival Clinical Trials

Regeneron to Acquire 23andMe for $256 Million in Bankruptcy Sale

The deal, pending court approval, includes 23andMe’s genetic data and services but excludes its Lemonaid Health subsidiary.

Colossal Biosciences Unveils Genetically Engineered Wolf Pups with Shadow Wolf Traits

Scientists Debate Safety and Ethics of Embryo Genome Editing to Prevent Disease

Deaf Mosquitoes Could Halt Disease Spread by Eliminating Mating

23andMe Board Resigns Amid CEO's Privatization Push